Overview

Human Papillomavirus (HPV) Vaccines Market is estimated to reach over USD 11 billion by 2027 end with a CAGR of over 16% during the forecast period 2020 to 2027.

The rising prevalence of HPV related cancers like oropharynx, genital parts and anal coupled with an increased insistence of HPV vaccines in reducing the infections are some of the key factors contributing to the human papillomavirus vaccines market growth. Asper the data provided by the Center for Disease Control and Prevention, the high prevalence rates for vulva, cervical and vaginal cancer were registered in 2018. Moreover, There has been a rise in the rate of manufacturing HPV vaccines owing to rising demand shall propel the market growth. Ethiopia’s Ministry of Health introduced HPV vaccines in the country as there has been a significant rise in the number of HPV patients, especially for girls aged 14 years and above to increase their immunity to cervical cancer. Additionally, girls in Kenya have also been provided with vaccinations and this shall accelerate the market proliferation over the upcoming years. Most importantly, the WHO issued an action call for eradicating cervical cancer across the world in May 2018 which, with the help of increased coverage across all the nations, is predicted to boost the insistence for HPV vaccines by over 100 million doses over the next decade, thereby propelling the market growth.   

Human Papillomavirus (HPV) Vaccines Market

Market Segmentation:

By Type
•    Bivalent
•    Polyvalent
By Disease Indication
•    HPV Associated Cancer
•    Genital Warts
By Distribution Channel
•    Hospitals and Retail Pharmacies
•    Government Suppliers 
•    Others
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into type, disease indication, distribution channel and region. The type segment is divided into bivalent and polyvalent. The disease indication segment is classified into HPV associated cancer and genital warts. The HPV associated cancer is predicted to account the largest human papillomavirus vaccines market share owing to the rising prevalence of cervical cancers in countries with the largest youth population. The distribution channel segment is bifurcated into hospitals and retail pharmacies, government suppliers and others. The hospital and retail pharmacy segment is anticipated to lead the market owing to advancements in healthcare infrastructure and increasing number of HPV patient population across the word. 

Regional Analysis:

The North America region is predicted to dominate the market during the forecast period owing to growing investments in research and development of advanced HPV vaccines along with a strong presence of key market players in the region. Merck, for instance, produced Gardasil in 2006 which could prevent infection from four HPV strains- 6,11, 16 and 18. Gardasil 9, as of 2017 is the only available HPV vaccine in the United States which was approves by FDA in December 2014. Such a limited availability of HPV vaccines has paved way for key players to conduct research activities for developing newer vaccines in the region.

Competitive Landscape:                            

The key players of the market associated are Emergent BioSolutions Inc., MedImmune LLC, Merck and Co., CSL Ltd., Sanofi Pasteur, Johnson and Johnson, GlaxoSmithKline, Pfizer, Astellas Pharma Inc., Serum Institute. 

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global human papillomavirus (HPV) vaccines market by type, by disease indication, by distribution channel and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics